NCT02638597View on ClinicalTrials.gov

Gemfibrozil for Nicotine Smoking Cessation

PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

December 23, 2016

Study Completion Date

December 23, 2016

Conditions
Smoking Cessation
Interventions
DRUG

Gemfibrozil

FDA Approved Drug(s)/Biologic(s) (study use is not an FDA-approved use)

BEHAVIORAL

smoking cessation counseling

smoking cessation counseling

Trial Locations (1)

75235

Parkland Memorial Hospital, Dallas

All Listed Sponsors
lead

University of Texas Southwestern Medical Center

OTHER

NCT02638597 - Gemfibrozil for Nicotine Smoking Cessation | Biotech Hunter | Biotech Hunter